(MedPage Today) — Federal regulators are trying to make it easier to develop cheaper alternatives to biologics that many Americans depend on to treat autoimmune diseases or cancers.
The FDA said Wednesday it has released guidance to simplify…
Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/118219
Author :
Publish date : 2025-10-29 20:21:00
Copyright for syndicated content belongs to the linked Source.
